Annie Pardo Selected Research

Annie Pardo Research Topics

Disease

36	Fibrosis (Cirrhosis) 01/2022 - 03/2003
29	Idiopathic Pulmonary Fibrosis 01/2024 - 04/2002
20	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2021 - 03/2002
12	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2022 - 01/2006
9	Inflammation (Inflammations) 12/2021 - 01/2002
8	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2024 - 01/2006
8	Lung Injury 01/2019 - 03/2003
4	Pneumonia (Pneumonitis) 11/2015 - 05/2003
3	Lung Diseases (Lung Disease) 01/2019 - 08/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 07/2021 - 11/2017
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 01/2017
2	Bronchiectasis 10/2017 - 08/2012
2	Disease Progression 04/2015 - 05/2010
2	Neoplasms (Cancer) 08/2013 - 03/2007
2	Cicatrix (Scar) 12/2011 - 06/2006
2	Carcinogenesis 11/2008 - 03/2007
1	Starvation 12/2016
1	Hyperplasia 10/2016
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 03/2014
1	Wounds and Injuries (Trauma) 09/2013
1	Lung Neoplasms (Lung Cancer) 08/2013
1	Glioma (Gliomas) 12/2012
1	Asymptomatic Infections 11/2011
1	Infections 11/2011

Drug/Important Bio-Agent (IBA)

24	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 04/2002
9	AntigensIBA 05/2024 - 07/2007
8	Metalloproteases (Metalloproteinases)IBA 01/2021 - 04/2002
7	CollagenIBA 01/2017 - 08/2005
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2008
6	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 05/2003
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2008
4	MicroRNAs (MicroRNA)IBA 12/2021 - 07/2010
4	indium-bleomycinIBA 01/2018 - 03/2003
3	Surface-Active Agents (Surfactants)IBA 01/2022 - 04/2015
3	Mitochondrial DNA (mtDNA)IBA 01/2020 - 01/2017
3	EnzymesIBA 01/2020 - 03/2003
3	CytokinesIBA 01/2019 - 08/2002
3	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2015 - 02/2012
3	OligonucleotidesIBA 01/2006 - 03/2002
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2008
2	AsbestosIBA 01/2020 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2019
2	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 04/2015
2	Ephrin-B2 (Ephrin B2)IBA 12/2017 - 12/2017
2	IntegrinsIBA 01/2017 - 09/2011
2	Therapeutic UsesIBA 10/2016 - 11/2011
2	lysophosphatidic acidIBA 01/2016 - 01/2008
2	Hydroxyproline (4 Hydroxyproline)IBA 11/2015 - 05/2013
2	Matrix Metalloproteinase 7 (Matrilysin)IBA 04/2012 - 04/2002
2	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 02/2004 - 11/2003
2	SmokeIBA 10/2003 - 05/2003
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2003 - 03/2003
1	Mitochondrial Permeability Transition PoreIBA 07/2021
1	AntibodiesIBA 06/2021
1	1-aminopropenal acetic acidIBA 06/2021
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 03/2021
1	Autophagy-Related ProteinsIBA 01/2020
1	Oxidants (Oxidizing Agents)IBA 01/2020
1	DNA Glycosylases (DNA Glycosylase)IBA 01/2020
1	TensinsIBA 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020
1	8-hydroxyguanineIBA 01/2020
1	Matrix Metalloproteinase 13IBA 01/2019
1	TunicamycinIBA 08/2018
1	Serine Proteases (Serine Protease)IBA 01/2018
1	Fibrillar CollagensIBA 01/2018
1	DisintegrinsIBA 12/2017
1	Extracellular Matrix ProteinsIBA 01/2017
1	Sirtuin 3IBA 01/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2016
1	PP242IBA 12/2016
1	Sirolimus (Rapamycin)FDA Link 12/2016
1	Fibroblast Growth Factor 1 (FGF-1)IBA 10/2016
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2016
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Mitogen-Activated Protein KinasesIBA 11/2015
1	AerosolsIBA 11/2015
1	Annexin A5IBA 11/2015
1	Cre recombinaseIBA 04/2015
1	Protein CIBA 04/2015
1	Laminin (Merosin)IBA 04/2015
1	matrix metalloproteinase 19IBA 03/2015
1	Dehydroepiandrosterone (DHEA)IBA 11/2013
1	StaurosporineIBA 09/2013
1	telomerase RNA (bTR)IBA 08/2013
1	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2013
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 08/2013
1	Transcription Factors (Transcription Factor)IBA 12/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2012
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 08/2012
1	Proteasome InhibitorsIBA 02/2012
1	Bortezomib (Velcade)FDA Link 02/2012
1	Immunomodulating AgentsIBA 11/2011
1	ChemokinesIBA 11/2011
1	Interleukin-6 (Interleukin 6)IBA 11/2011
1	Messenger RNA (mRNA)IBA 09/2011

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2002
2	Traction 10/2017 - 08/2012
1	Precision Medicine 01/2024